NCT07243470: Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 70 planned
- Started
- 4 Nov 2025
- Primary completion
- Oct 2029
- Arms
- Patients with IDH-mutant glioma, Patients with other glioma, Patients with other CNS tumors
- Results
- None posted
- 4 Nov 2025: Trial started
- 24 Nov 2025: Trial registered